KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Teladoc Health (TDOC) Interest & Investment Income (2022 - 2025)

Teladoc Health's Interest & Investment Income history spans 4 years, with the latest figure at $7.0 million for Q4 2025.

  • For Q4 2025, Interest & Investment Income fell 51.16% year-over-year to $7.0 million; the TTM value through Dec 2025 reached $36.8 million, down 35.57%, while the annual FY2025 figure was $36.8 million, 35.57% down from the prior year.
  • Interest & Investment Income for Q4 2025 was $7.0 million at Teladoc Health, down from $7.1 million in the prior quarter.
  • Across five years, Interest & Investment Income topped out at $15.3 million in Q3 2024 and bottomed at $4.8 million in Q3 2022.
  • The 4-year median for Interest & Investment Income is $12.1 million (2023), against an average of $10.9 million.
  • The largest annual shift saw Interest & Investment Income surged 162.46% in 2023 before it crashed 53.8% in 2025.
  • A 4-year view of Interest & Investment Income shows it stood at $6.5 million in 2022, then surged by 111.46% to $13.7 million in 2023, then rose by 3.82% to $14.2 million in 2024, then tumbled by 51.16% to $7.0 million in 2025.
  • Per Business Quant, the three most recent readings for TDOC's Interest & Investment Income are $7.0 million (Q4 2025), $7.1 million (Q3 2025), and $10.1 million (Q2 2025).